Lv511
860 积分 2026-04-18 加入
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
12天前
已完结
Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death
12天前
已完结
Stimuli-Responsive DNA Tetrahedral Lysosome-Targeting Chimeras for Enhanced HER2 Protein Degradation
14天前
已完结
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
14天前
已完结
Discovery of potent and selective HER2 PROTAC degrader based Tucatinib with improved efficacy against HER2 positive cancers
14天前
已完结
Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach
16天前
已完结
Comparative anti-proliferative effects of potential HER2 inhibitors on a panel of breast cancer cell lines
16天前
已完结
Design, synthesis, antiproliferative activity, and molecular dynamics simulation of pyrazoline-based derivatives as dual EGFR and HER-2 inhibitors
16天前
已完结
Design and synthesis of novel pyrrolo[2,3-d]pyrimidine derivatives as potent JAK3 and SYK dual inhibitors
16天前
已完结
Identification of potential inhibitors of HER2 targeting breast cancer—a structure-based drug design approach
16天前
已完结
皖公网安备34019202002308
